BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 35038974)

  • 1. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis.
    Li G; Zong W; Liu L; Wu J; Pang J
    Bioengineered; 2022 Feb; 13(2):2791-2802. PubMed ID: 35038974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis.
    Hu WN; Duan ZY; Wang Q; Zhou DH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7628-7638. PubMed ID: 31539155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of LINC00657 inhibits ox-LDL-induced endothelial cell injury by regulating miR-30c-5p/Wnt7b/β-catenin.
    Wu H; Liu T; Hou H
    Mol Cell Biochem; 2020 Sep; 472(1-2):145-155. PubMed ID: 32577947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway.
    Guo J; Li J; Zhang J; Guo X; Liu H; Li P; Zhang Y; Lin C; Fan Z
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3508-3521. PubMed ID: 34627697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes-Mediated LncRNA ZEB1-AS1 Facilitates Cell Injuries by miR-590-5p/ETS1 Axis Through the TGF-β/Smad Pathway in Oxidized Low-density Lipoprotein-induced Human Umbilical Vein Endothelial Cells.
    Chen D; Wang K; Zheng Y; Wang G; Jiang M
    J Cardiovasc Pharmacol; 2021 Apr; 77(4):480-490. PubMed ID: 33818551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis.
    Guo JT; Wang L; Yu HB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9633-9644. PubMed ID: 33015807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
    Zheng Z; Zhang G; Liang X; Li T
    Mol Cell Biochem; 2021 Jan; 476(1):443-455. PubMed ID: 32990894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4.
    Lu G; Tian P; Zhu Y; Zuo X; Li X
    J Biosci; 2020; 45():. PubMed ID: 32345778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA OIP5-AS1 accelerates ox-LDL-treated HUVECs injury by NF-κB pathway via miR-30c-5p.
    Zhang L; Li Q; Chen Y; Zhu Q
    Clin Hemorheol Microcirc; 2021; 78(4):449-460. PubMed ID: 33867356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway.
    Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C
    J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0004831 downregulation is partially responsible for atorvastatinalleviated human umbilical vein endothelial cell injuries induced by ox-LDL through targeting the miR-182-5p/CXCL12 axis.
    Su G; Sun G; Lv J; Zhang W; Liu H; Tang Y; Su H
    BMC Cardiovasc Disord; 2021 May; 21(1):221. PubMed ID: 33932991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
    Wang K; Yang C; Shi J; Gao T
    Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA-PTPRA Knockdown Inhibits Atherosclerosis Progression by Repressing ox-LDL-Induced Endothelial Cell Injury via Sponging of miR-671-5p.
    Luo X; Zhou X
    Biochem Genet; 2023 Feb; 61(1):187-201. PubMed ID: 35817886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PVT1 regulates atherosclerosis progression via the microRNA-106b-5p/ACSL4 axis.
    Zhang M; Yu Z; Zhao L; Luo H
    Biochem Biophys Res Commun; 2023 Jul; 667():170-179. PubMed ID: 37236049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p.
    Wang G; Li Y; Liu Z; Ma X; Li M; Lu Q; Li Y; Lu Z; Niu L; Fan Z; Lei Z
    Mol Cell Biochem; 2020 Aug; 471(1-2):51-61. PubMed ID: 32500475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ox-LDL-induced endothelial cell injury by LINC02381 knockdown through the microRNA-491-5p/transcription factor 7 axis.
    Zhu X; Xu H; Chen B
    Immun Inflamm Dis; 2023 Mar; 11(3):e785. PubMed ID: 36988257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircIRAK1 aggravates ox-LDL-induced endothelial cell injury in atherosclerosis via TRIM14 upregulation by binding to miR-330-5p.
    Liu F; Gao B; Wang Y
    Clin Hemorheol Microcirc; 2023; 85(3):195-209. PubMed ID: 36336926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA ZFAS1 promotes ox-LDL induced EndMT through miR-150-5p/Notch3 signaling axis.
    Yin Q; He M; Huang L; Zhang X; Zhan J; Hu J
    Microvasc Res; 2021 Mar; 134():104118. PubMed ID: 33278458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG12 regulates ox-LDL-induced endothelial cell injury by the miR-218-5p/IGF2 axis in atherosclerosis.
    Mao P; Liu X; Wen Y; Tang L; Tang Y
    Cell Cycle; 2021 Aug; 20(16):1561-1577. PubMed ID: 34313533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_USP36 Silencing Attenuates Oxidized Low-Density Lipoprotein-Induced Dysfunction in Endothelial Cells in Atherosclerosis Through Mediating miR-197-3p/ROBO1 Axis.
    Zhang Y; Li W; Li H; Zhou M; Zhang J; Fu Y; Zhang C; Sun X
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e761-e772. PubMed ID: 34369900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.